medifoxamine
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
SummaryMedifoxamine is a monoamine reuptake inhibiting antidepressant drug. We have investigated its pharmacokinetics in normal…
The serotonin (5-HT) is implicated in many centrally-regulated functions and has shown to be involved in affective disorders…
Medifoxamine (Clédial TM), a non tricyclic non MAOI antidepressant drug with a dopaminergic and serotoninergic mechanism of…
Medifoxamine is a novel monoamine re-uptake inhibiting antidepressive drug which preferentially inhibits dopamine reuptake. In…
Medifoxamine is a new monoamine re-uptake inhibiting antidepressant drug. Twelve volunteers received 100 mg by i.v. infusion over…
Medifoxamine is a new antidepressant drug which is in clinical use in France and is undergoing clinical investigation elsewhere…
Ten volunteers received single oral doses of medifoxamine 50 and 100 mg, atropine 1 mg, amitriptyline 50 mg or placebo in random…
Medifoxamine is a new investigational antidepressant drug. Its buccal absorption at pH 5–9, which can be considered as an in‐vivo…